Improved outcomes in E2A::HLF positive B-cell acute lymphoblastic leukemia by chimeric antigen receptor T cell therapy and BCL-2 inhibitor-Reference-Cited by-同舟云学术

Improved outcomes in E2A::HLF positive B-cell acute lymphoblastic leukemia by chimeric antigen receptor T cell therapy and BCL-2 inhibitor

Published:2023-02-15 Issue:11 Volume:136 Page:1382-1384
ISSN:0366-6999
Container-title:Chinese Medical Journal
language:en
Short-container-title:

Author:

Chen Shumin¹,Li Ye¹,Wang Zheng¹,Feng Lin¹,Jia Yueping²,Mo Xiaodong¹,Wang Yu¹,Jiang Qian¹,Huang Xiaojun¹³,Lai Yueyun¹

Affiliation:

1. Peking University Institute of Hematology, Peking University People's Hospital, Beijing 100044, China

2. Department of Pediatrics, Peking University People's Hospital, Beijing 100044, China

3. Research Unit of Key Technique for Diagnosis and Treatments of Hematologic Malignancies, Chinese Academy of Medical Sciences (2019RU029), Beijing 100044, China.

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

General Medicine,General Medicine

Reference7 articles.

1. Genomics and drug profiling of fatal TCF3-HLF-positive acute lymphoblastic leukemia identifies recurrent mutation patterns and therapeutic options;Fischer;Nat Genet,2015

2. Successful preemptive donor lymphocyte infusions from a haploidentical donor in a boy with E2A-HLF-positive ALL;Hirai;Leuk Lymphoma,2018

3. Durable remissions in TCF3-HLF positive acute lymphoblastic leukemia with blinatumomab and stem cell transplantation;Mouttet;Haematologica,2019

4. The first case of elderly TCF3-HLF-positive B-cell acute lymphoblastic leukemia;Takeda;Leuk Lymphoma,2019

5. Long-Term follow-up of CD19 CAR therapy in acute lymphoblastic leukemia;Park;N Engl J Med,2018

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Cytarabine/methotrexate;Reactions Weekly;2023-07-29